People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous ...

Philips Respironics has issued another ventilator recall deemed the most serious type by the FDA as it may cause serious injury or death.

Airway Management proudly announces a historic milestone with the FDA clearance of Nylon flexTAP ® , the world’s first digitally printed single-point midline oral appliance device for sleep apnea.

A simple nighttime breathing device may dramatically improve survival for people living with both type 2 diabetes and ...

Results from a multicenter clinical trial, now published in the European Journal of Pediatrics, represent a significant milestone in the fight against one of the most underdiagnosed and undertreated ...

Snoring and sleep apnea are issues that affect thousands of people across Hawai‘i, and while CPAP machines are often ...

Despite media reports suggesting a fresh investigation, France has not initiated a new probe into Philips' recall of sleep ...

Nyxoah announced today that it filed a lawsuit against Inspire Medical Systems alleging the infringement of sleep apnea ...

Philips Respironics has removed certain DreamStation devices due to programming errors that can result in failed therapy modes, according to the U.S. Food and Drug Administration.

A post hoc analysis of three major clinical trials finds that CPAP therapy lowers the risk for cardiovascular events only in ...

Paris prosecutors opened a criminal probe into Philips in June over its recall of sleep apnea devices, probing possible ...

A centuries-old tradition may soon find a place in modern medicine. Researchers have discovered that a simple breathing ...